PGEN vs USB · rev $1.8M vs P/E 12, rev $28.66B
Precigen Inc (PGEN) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Precigen Inc (PGEN) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported PGEN revenue for 2023-06-30 was $1.8M. Net income was -$20.3M. Revenue was down 4.5% from 2023-03-31 to 2023-06-30. PGEN currently screens at market cap $419.2M.
Latest reported USB revenue for 2025-12-31 was $28.66B. Net income was $7.57B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. USB currently screens at market cap $74.68B and trailing P/E 11.9.
PGEN currently screens at market cap $419.2M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the PGEN and USB stock pages for the full models.
Not investment advice.